1-[2-(1,3-dihydroisoindol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]-2,2-dimethylpropan-1-one;2,2-dimethyl-1-[2-[3-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-7-yl]propan-1-one
C43H44F3N11O2 — CID 67343914
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[2-(1,3-dihydroisoindol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]-2,2-dimethylpropan-1-one;2,2-dimethyl-1-[2-[3-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-7-yl]propan-1-one
1-[2-(1,3-dihydroisoindol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]-2,2-dimethylpropan-1-one;2,2-dimethyl-1-[2-[3-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-7-yl]propan-1-one (PubChem CID 67343914) has the molecular formula C43H44F3N11O2 and a molecular weight of 803.89 g/mol. Its IUPAC name is 1-[2-(1,3-dihydroisoindol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]-2,2-dimethylpropan-1-one;2,2-dimethyl-1-[2-[3-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-7-yl]propan-1-one.
Molecular Properties
| Compound Name | 1-[2-(1,3-dihydroisoindol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]-2,2-dimethylpropan-1-one;2,2-dimethyl-1-[2-[3-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-7-yl]propan-1-one |
|---|---|
| PubChem CID | 67343914 |
| Molecular Formula | C43H44F3N11O2 |
| Molecular Weight | 803.89 g/mol |
| Exact Mass | 803.36 |
| IUPAC Name | 1-[2-(1,3-dihydroisoindol-2-yl)-5H-pyrrolo[2,3-b]pyrazin-7-yl]-2,2-dimethylpropan-1-one;2,2-dimethyl-1-[2-[3-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]-5H-pyrrolo[2,3-b]pyrazin-7-yl]propan-1-one |
| SMILES | CC(C)(C)C(=O)c1c[nH]c2ncc(-c3cccc(CN4CCn5c(nnc5C(F)(F)F)C4)c3)nc12.CC(C)(C)C(=O)c1c[nH]c2ncc(N3Cc4ccccc4C3)nc12 |
| InChI | InChI=1S/C24H24F3N7O.C19H20N4O/c1-23(2,3)20(35)16-10-28-21-19(16)30-17(11-29-21)15-6-4-5-14(9-15)12-33-7-8-34-18(13-33)31-32-22(34)24(25,26)27;1-19(2,3)17(24)14-8-20-18-16(14)22-15(9-21-18)23-10-12-6-4-5-7-13(12)11-23/h4-6,9-11H,7-8,12-13H2,1-3H3,(H,28,29);4-9H,10-11H2,1-3H3,(H,20,21) |
| InChIKey | JIJCAEILKDPFOO-UHFFFAOYSA-N |
| XLogP | 8.19 |
| TPSA | 154.47 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 59 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 803.89 |
| LogP ≤ 5 | 8.19 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 67343914 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.